Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1425 of 6351
-
New hope for DVT patients when blood thinners fail
Disease control Not yet recruitingThe goal of this study is to fill the paucity of second line endovascular treatment for acute deep venous thrombus (DVT) by using catheter-directed thrombolysis (CDT) and mechanical thrombectomy (MT) as adjunctive second-line treatments for acute DVT patients who show no improvem…
Phase 4 • Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
AI heart scans could replace MRI for chemo patients
Diagnosis Not yet recruitingTo investigate the clinical utility of both 3D and 2D artificial intelligence reconstruction echocardiography (V-echo and L-echo) assessment against conventional echocardiography and clinical cardiovascular magnetic resonance (CMR) imaging for the characterisation of cardiac func…
Sponsor: The Royal Wolverhampton Hospitals NHS Trust • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
Heart failure study questions need for frequent kidney checks
Disease control Not yet recruitingGuideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) constitutes of four medications that substantially reduce morbidity and mortality, and improve quality of life. In routine clinical practice, various physician- and patient-related …
Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Blocking blood flow before surgery may help remove inoperable bile duct cancer
Disease control Not yet recruitingThis is a prospective, multicenter, single-arm study investigating the efficacy and safety of preoperative right hepatic artery embolization (PHAE) followed by surgical resection in patients with locally advanced Bismuth IIIb or IV perihilar cholangiocarcinoma (PHCC) involving th…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Heart attack prediction breakthrough? new AI reads ECG to spot artery blockages
Diagnosis Not yet recruitingThe study objective is to evaluate the effectiveness of the ECGio algorithm in predicting clinically significant coronary artery disease . ECGio's diagnostic performance during the trial will be compared against an objective performance ¬criteria using a mixed reference standard …
Sponsor: Heart Input Output Inc • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
AI-Powered 1-Minute ECG could spot hidden heart risks
Diagnosis Not yet recruitingIt is a prospective, controlled, single-center, observational, non-randomized study. The study is planned to include at least 4000 patients 18 years old and older in the training sample and 1000 patients over 18 years old in the test sample (the total number of patients is at lea…
Sponsor: I.M. Sechenov First Moscow State Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 12:08 UTC
-
Double balloon blast may boost TAVI valve fit
Disease control Not yet recruitingThe goal of this clinical trial is to discover if routine 'double tap' balloon post-dilation improves valve expansion and clinical outcomes in adults undergoing Transcatheter Aortic Valve Implantation (TAVI) with the SAPIEN balloon-expandable TAVI prosthesis. The primary hypothe…
Sponsor: The Alfred • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New drug combo targets advanced cancers in early trial
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the safety, tolerability, pharmacokinetics (PK), and effectiveness of the investigational drug QLS5132 (injectable) in combination with other therapies for participants with advanced solid tumors. This is a multicenter, open-label st…
Phase 1/2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Cannabis oil trial aims to ease cancer Patients' daily suffering
Symptom relief Not yet recruitingCAPTURE is a prospective, interventional, randomized, phase 2, double-blind, placebo-controlled study assessing the therapeutic add-on effect of the balanced THC/CBD extract (Cannabis extract Avextra 10/10 oral solution) on symptom burden in patients with advanced oncological dis…
Phase 2 • Sponsor: National Cancer Institute, Naples • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
One-Patient trial aims to treat Ultra-Rare genetic disorder
Disease control Not yet recruitingThis research project entails delivery of a personalized antisense oligonucleotide (ASO) drug intended for a single participant with Schuurs-Hoeijmakers syndrome (SHMS) due to a pathogenic, de novo, heterozygous missense gain-of-function mutation in PACS1
Phase 1/2 • Sponsor: n-Lorem Foundation • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Resilience training aims to shield first responders from PTSD
Prevention Not yet recruitingAs a result of chronic exposures to traumatic and stressful events, first responders are at elevated risk for experiencing post-traumatic stress disorder (PTSD) and other mental health problems. Resilience training can reduce the risk for developing mental health symptoms in firs…
Sponsor: Stony Brook University • Aim: Prevention
Last updated Jun 27, 2026 12:10 UTC
-
Could a stronger blood thinner save trauma patients from deadly clots?
Prevention Not yet recruitingVenous thromboembolism is a frequent issue in severe trauma patients. Guidelines for venous thromboembolism prevention include the use of pharmacological thromboprophylaxis, mainly with low-molecular-weight heparin, and/or mechanical thromboprophylaxis. However, a high incidence …
Sponsor: University Hospital, Grenoble • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC
-
Could a common drug prevent brain swelling after stroke?
Disease control Not yet recruitingThis is a prospective, multicenter, randomized controlled clinical study aimed at evaluating the efficacy of butylphthalide in improving the severity of cerebral edema and prognosis in patients with acute anterior circulation large vessel occlusion after endovascular treatment.
Phase 4 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can a simple saltwater drip improve stroke outcomes? new trial aims to find out.
Disease control Not yet recruitingThe intravenous administration of abundant normal saline is an easy-to-use strategy commonly employed to expand the blood volume. This study aimed to evaluate the efficacy and safety of the early administration of an abundant normal saline infusion after intravenous thrombolysis …
Phase 3 • Sponsor: Tianjin Medical University General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Immune cells injected into brain to fight tumors
Disease control Recruiting nowThis is a multi-center, open-label investigator-initiated trial (IIT) designed to evaluate the safety, tolerability, and feasibility of combined intracranial and intravenous administration of ex vivo expanded and activated natural killer (NK) cells in adult patients with malignan…
Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New pacing technique aims to stop irregular heartbeat in heart failure patients
Disease control Not yet recruitingThis is a multi-center, prospective, single-blind, randomized controlled clinical trial to evaluate the efficacy and safety of Bachmann bundle pacing (BBP) in preventing new-onset atrial fibrillation (AF) in patients with chronic cardiac insufficiency who have indications for car…
Sponsor: Fu Wai Hospital, Beijing, China • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can CBD oil stop migraines before they start? new trial aims to find out
Disease control Recruiting nowThis study will evaluate the efficacy and safety of cannabis for the treatment of chronic migraine headaches. Study subjects will be randomized to one of three groups: lower dose CBD, higher dose CBD or placebo.
Phase 2 • Sponsor: University of Calgary • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Can an oxygen gel heal medication-damaged jaw bone better than a blood-derived patch?
Disease control OngoingA randomized clinical trial comparing Blue®m oral gel and autologous PRF membrane as adjuncts to surgical debridement in BRONJ/MRONJ patients.
Sponsor: Mansoura University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Magic mushroom compound may rewire Self-Awareness — scientists put it to the test
Knowledge-focused Recruiting nowSelf-awareness, the capacity of becoming the object of one's own awareness, is a frontier of scientific knowledge. Over centuries, distinct philosophical and religious traditions have grappled with the subject, but only recently has the importance of self-awareness been establish…
Early phase 1 • Sponsor: Pontifícia Universidade Católica do Rio de Janeiro • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
Can a CT scan predict the future of gastric cancer?
Knowledge-focused Recruiting nowThe goal of this prospective observational study is to evaluate how well a previously developed prediction model can estimate outcomes in adults with gastric cancer. The model combines information from computed tomography (CT) images obtained before treatment with routine clinica…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC